Postoperative caffeine for preventing apnea in preterm infants

Area of Science:

• Neonatalogy
• Pediatric Surgery
• Pharmacology

Background:

• Ex-preterm infants undergoing surgery around term-equivalent age are at risk for postoperative apnea, cyanosis, and bradycardia.
• Prophylactic caffeine administration is being investigated as a potential preventive measure.

Purpose of the Study:

• To evaluate the efficacy and safety of prophylactic caffeine in preventing postoperative apnea, cyanosis, and bradycardia in ex-preterm infants.
• To assess for clinically important side effects associated with caffeine treatment.

Main Methods:

• Systematic review and meta-analysis of randomized controlled trials comparing caffeine to placebo or no treatment.
• Searches conducted in major databases including Oxford Database of Perinatal trials and Medline.
• Methodological quality assessed, and data extracted by independent reviewers.

Main Results:

• Caffeine treatment significantly reduced episodes of apnea/bradycardia in treated infants compared to controls.
• Oxygen desaturation episodes were less frequent in infants receiving caffeine.
• No infants required intubation or mechanical ventilation, and no adverse effects were reported.

Conclusions:

• Caffeine is effective in preventing postoperative apnea/bradycardia and oxygen desaturation in growing preterm infants when clinically indicated.
• Caution is recommended for routine clinical practice due to small study populations and uncertain clinical significance of observed episodes.
• Further research is needed to identify specific infant subgroups who would benefit most from prophylactic caffeine therapy.